Adlai Nortye Ltd.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANL and other ETFs, options, and stocks.About ANL
Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment.
CEOYang Lu
CEOYang Lu
Employees123
Employees123
HeadquartersHangzhou, Zhejiang
HeadquartersHangzhou, Zhejiang
Founded2018
Founded2018
Employees123
Employees123
ANL Key Statistics
Market cap37.27M
Market cap37.27M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume15.88K
Average volume15.88K
High today$1.33
High today$1.33
Low today$1.00
Low today$1.00
Open price$1.24
Open price$1.24
Volume57.64K
Volume57.64K
52 Week high$2.99
52 Week high$2.99
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
Adlai Nortye Ltd.(ANL) stock is priced at $1.01, giving the company a market capitalization of 37.27M.
As of 2025-12-07, Adlai Nortye Ltd.(ANL) stock has fluctuated between $1.00 and $1.33. The current price stands at $1.01, placing the stock +1.0% above today's low and -24.1% off the high.
Adlai Nortye Ltd.(ANL) shares are trading with a volume of 57.64K, against a daily average of 15.88K.
During the past year, Adlai Nortye Ltd.(ANL) stock moved between $1.00 at its lowest and $2.99 at its peak.
During the past year, Adlai Nortye Ltd.(ANL) stock moved between $1.00 at its lowest and $2.99 at its peak.